BERKELEY, Calif., Feb. 2, 2009 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that Steven Engle, Chairman and Chief Executive Officer of XOMA, is scheduled to present at the Biotechnology Industry Organization BIO CEO & Investor Conference. The presentation will take place in New York on February 9 at 3:45 P.M.
